JOINT CONFERENCE COMMITTEE REPORT

We, the conferees, appointed by the respective bodies to consider and report upon the disagreeing vote on House Bill No. 1087, report as follows:

A. We recommend that the Senate Amendment in the Nature of a Substitute (18107714D) be rejected.

B. We recommend that the engrossed bill be accepted with the following amendments to resolve the matter under disagreement:

1. Line 47, engrossed, after § 321,

strike

or

2. Line 47, engrossed, after products

insert

, or any other products regulated by the U.S. Food and Drug Administration, except for any product regulated under Subchapter VI of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.)

Respectfully submitted,

Delegate Jennifer B. Boysko

Delegate James E. Edmunds, II

Delegate James W. Morefield

Conferees on the part of the House

Senator William M. Stanley, Jr.

Senator J. Chapman Petersen

Senator Richard H. Black

Conferees on the part of the Senate